
Biote Corp (BTMD) Stock Forecast & Price Target
Biote Corp (BTMD) Analyst Ratings
Bulls say
Biote is expected to have a prolonged time horizon to drive sustainable growth in doctor adds, procedures and AEBITDA due to negative procedure rev/KPIs. Unfavorable acceptance trends among clinics, practitioners, and patients may hinder the company's growth and profitability, as it largely relies on practitioner awareness and adoption of its practice-building platform and supplements. Additionally, practitioners' potential reluctance to change their medical treatment practices to incorporate Biote's offerings may impact their adoption of the Biote Method and supplements.
Bears say
Biote is facing several challenges, including risks associated with international expansion, a low valuation, and difficulties in acquiring and retaining new clinics. Furthermore, a heavy reliance on key personnel and uncertainties around their sales and technology platform may impact future growth and profitability. Additionally, potential risks such as economic, regulatory, and political factors, as well as inflation and data security breaches, may also have a negative impact on the company's performance.
This aggregate rating is based on analysts' research of Biote Corp and is not a guaranteed prediction by Public.com or investment advice.
Biote Corp (BTMD) Analyst Forecast & Price Prediction
Start investing in Biote Corp (BTMD)
Order type
Buy in
Order amount
Est. shares
0 shares